home / stock / pacb / pacb news


PACB News and Press, Pacific Biosciences of California Inc. From 02/15/24

Stock Information

Company Name: Pacific Biosciences of California Inc.
Stock Symbol: PACB
Market: NASDAQ
Website: pacb.com

Menu

PACB PACB Quote PACB Short PACB News PACB Articles PACB Message Board
Get PACB Alerts

News, Short Squeeze, Breakout and More Instantly...

PACB - Pacific Biosciences of California Non-GAAP EPS of -$0.27 beats by $0.01, revenue of $58.36M in-line

2024-02-15 16:10:07 ET More on Pacific Biosciences of California Why Is Pacific Biosciences' Price Action So Bad? (Downgrade) Pacific Biosciences: Strong Cash And Doubling Revenue Signal Investment Growth Pacific Biosciences' Revio And Onso Lead Looks Priced In For N...

PACB - PacBio Announces Fourth Quarter and Fiscal Year 2023 Financial Results

PacBio Announces Fourth Quarter and Fiscal Year 2023 Financial Results PR Newswire MENLO PARK, Calif. , Feb. 15, 2024 /PRNewswire/ -- PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2023. ...

PACB - Expected US Company Earnings on Thursday, February 15th, 2024

Propanc Biopharma Inc (PPCB) is expected to report for Q2 2024 Bank of Georgia Group Plc (BDGSF) is expected to report for quarter end 2023-12-31 Arch Resources Inc. Class A (ARCH) is expected to report $6.9 for Q4 2023 Bloom Energy Corporation Class A (BE) is expected to report $-0.0...

PACB - Notable earnings after Thursday's close

2024-02-14 17:35:58 ET Major earnings expected after the bell on Thursday include: Roku ( ROKU ) Coinbase Global ( COIN ) Applied Materials ( AMAT ) The Trade Desk ( TTD ) DraftKings ( DKNG ) Read the full article on Seeking Alpha For ...

PACB - Experiential Marketing Firm VOLO Events Agency Wins Best Event Technology Award for PacBio Product Launch

Experiential Marketing Firm VOLO Events Agency Wins Best Event Technology Award for PacBio Product Launch PR Newswire ATLANTA , Feb. 13, 2024 /PRNewswire/ -- VOLO Events Agency (VOLO), a leading producer of experiential marketing and live events for global br...

PACB - Why Is Pacific Biosciences' Price Action So Bad? (Downgrade)

2024-02-12 13:06:08 ET Summary PacBio has reported strong financial performance, with a 113% growth in Q4 revenue and a 56% growth for the year. The launch of the Revio and Onso products has contributed to PacBio's growth and expansion in the genomic research market. However, ...

PACB - Pacific Biosciences: Strong Cash And Doubling Revenue Signal Investment Growth

2024-02-08 10:03:39 ET Summary PacBio's financials for 2023 show significant growth, with revenue more than doubling in Q4 and a 56% increase in annual revenue compared to the previous year. The company's product innovations, such as the Revio system and Onso sequencer, have drive...

PACB - PacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale

PacBio Announces HiFi Prep Kit 96 and HiFi Plex Prep Kit 96 for Long-Read Sequencing Applications at Scale PR Newswire New Library Preparation Solutions Offer Never Before Achieved Scale for the Revio™ Sequencing System MENLO PARK, Calif. , ...

PACB - PacBio to Report Fourth Quarter 2023 Financial Results on February 15, 2024

PacBio to Report Fourth Quarter 2023 Financial Results on February 15, 2024 PR Newswire MENLO PARK, Calif. , Jan. 25, 2024 /PRNewswire/ -- PacBio (NASDAQ: PACB) announced today that it will hold its quarterly conference call to discuss its fourth quarter 2023 fin...

PACB - Cantor picks RCEL as best 2024 medtech idea; bullish on PACB, AXGN, CERS

2024-01-21 16:50:33 ET More on Pacific Biosciences of California, AVITA Medical, etc. AVITA Medical Positioned For Stellar 2024 With Skin Repair Innovation Momentum Pacific Biosciences' Revio And Onso Lead Looks Priced In For Now Reassessing Pacific Biosciences: Deep...

Previous 10 Next 10